Suzhou Elon Technology Co., Ltd., a leader in smart medical solutions in China, focuses on providing overall solutions for intelligent management of medical supplies. As one of the first A-share professional enterprises, it covers smart pharmacies, hospitals, logistics and other sectors. It relies on the Internet of Things and big data technology, and uses automation and intelligent sensing technology to promote the efficient and safe management of medical supplies in medical institutions. The company has a clear shareholding structure and stable management, is a leader in technological innovation and patent achievements, and is committed to building an efficient new smart medical service system. The company's shareholding structure is clear and management is clear.
As of the 2023 three-quarter report, the top three shareholders of Elon Technology are Ms. Zhang Yinhua, Mr. Xu Li, and Zhufeng Asset Management (Beijing) Co., Ltd., with shareholding ratios of 29.86%, 10.96% and 2.88% respectively. Zhang Yinhua has voluntarily extended the lockdown period for its restricted shares, which expires on March 29, 2025, involving 23.55 million shares, accounting for 29.86% of the company's total share capital.
An industry leader in intelligent management solutions for medical supplies, providing comprehensive one-stop services. Relying on the Internet of Things and big data technology, the company has developed core business segments covering smart pharmacies, hospital areas, and logistics, with the aim of improving the service efficiency and safety of medical institutions. Elon Technology's products are widely used in various medical institutions, and new application scenarios are constantly being explored. The company combines independent production and outsourced processing to provide efficient and customized intelligent management solutions to the market through direct sales and distribution models.
Deepen the foundation of data elements, cultivate core competitiveness, and build a “moat” to continuously explore new urban management models. 1) A large amount of accumulated industry data: the company is deeply involved in midstream data collection and processing and downstream data application, and has rich spatial and temporal data accumulation; 2) Medium- and long-term strategic planning: based on data elements, the next three years will mainly focus on the two major fields of digital intelligence and comprehensive underground space management to actively promote the transformation and development of the company; 3) Jiangsu Urban Life Safety Line Project: The company has a good data foundation in Jiangsu Province and continues to build the Jiangsu Urban Life Safety Line Project, focusing on urban public safety management, and ultimately achieving a network of hidden risks to urban lifeline safety Accurate prediction and early warning.
Investment suggestion: The company is an overall solution provider for intelligent management of medical supplies. It has been deeply involved in the field of medical supplies management for many years, relying on the Internet of Things and human-computer interaction platforms built on big data analysis to promote product upgrading from “automation” to “intelligence”. In the context of artificial intelligence accelerating the deep empowerment of the industry, the company actively promotes intelligent medical care to cover larger scenarios, which is expected to open up room for long-term growth. The company's net profit for 2023-2025 is estimated to be 0.27/120/161 million yuan. The corresponding PE is 64X, 15X, and 11X, respectively, covered for the first time, and given a “recommended” rating.
Risk warning: market development risk; market demand change risk; OEM procurement model risk